Text size Moderna’s headquarters in Cambridge, Massachusetts. Joseph Prezioso / AFP / Getty Images Moderna’s announcement of positive data about a Phase 1 trial of its Covid-19 vaccine in May was met with skepticism by some experts, who noted that the company had not included many details about the trial’s …
Read More »
Moderna Inc.’s shares soared in the extended session Tuesday after the biotech company said its coronavirus vaccine candidate produced a “robust” immune system response in a larger group of people and the study will go on to a decisive clinical trial in July. Results published in The New England Journal …
Read More »
Tedros Adhanom Ghebreyesus, Director-General of the World Health Organization, attends a press conference on June 25 in Geneva. AP GENEVA – The head of the World Health Organization on Monday criticized some government leaders for eroding public confidence by sending contradictory messages about the coronavirus and warned that if they …
Read More »
Text size Maddie Meyer / Getty Images Moderna’s shares have risen 239% so far this year, and the biotech company, which has no approved medications, has a market capitalization of more than $ 24 billion. But in a note sent out Monday morning, Jefferies analyst Michael Yee writes that the …
Read More »
Modern (MRNA) – Get report it increased after Jefferies analyst Michael Yee began coverage of the biopharmaceutical company with a buy rating and a stock price target of $ 90, and Nasdaq said it would add the shares to the Nasdaq 100. The company’s coronavirus vaccine candidate could sell for …
Read More »